Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A

Clinical trial NCT02035384 · COMPLETED

Trial details

NCT number: NCT02035384
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2014-06-05
Primary completion: 2020-01-15
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.